Literature DB >> 30253445

Occurrence and characterization of carbapenem-resistant Gram-negative bacilli: A collaborative study of antibiotic-resistant bacteria between Indonesia and Japan.

Kuntaman Kuntaman1,2, Katsumi Shigemura3,4, Kayo Osawa5, Koichi Kitagawa6, Koharu Sato3, Naoki Yamada3, Kento Nishimoto3, Fukashi Yamamichi5, Dadik Rahardjo2, Usman Hadi1,7, Ni Made Mertaniasih1,2, Shohiro Kinoshita4, Masato Fujisawa4, Toshiro Shirakawa4,6,8.   

Abstract

OBJECTIVES: To explore the occurrence and characterization of carbapenemase-producing pathogens among carbapenem-resistant Gram-negative bacilli isolated from hospitalized patients with urinary tract infection in Indonesia.
METHODS: This was a study promoted by the Japanese-Indonesian collaborative research program in the Japan Initiative for Global Research Network on Infectious Diseases. Bacterial pathogens were prospectively isolated from urine specimens of hospitalized urinary tract infection patients at Dr. Soetomo Hospital (Surabaya, Indonesia). All Gram-negative bacteria resistant to third-generation cephalosporin or carbapenem were included in this study. Carbapenemase genes were investigated for phenotype and genotype.
RESULTS: In total, 1082 Gram-negative bacilli were isolated, of which 116 strains were resistant to imipenem or meropenem (carbapenem-resistant Gram-negative bacilli), and 22 strains were carbapenemase-producing Gram-negative bacilli. Carbapenemase-producing Gram-negative bacilli consisted of Acinetobacter baumannii (n = 4), Pseudomonas aeruginosa (n = 4), Klebsiella pneumoniae (n = 5), Providencia rettgeri (n = 4) and five others. The carbapenemase-producing Gram-negative bacilli included NDM-1 (n = 18, 81.8%, in Enterobacteriaceae and Acinetobacter spp.) and IMP-7 (n = 4, 18.2%, all in P. aeruginosa). Among carbapenem-resistant Gram-negative bacilli, all four P. aeruginosa were sensitive to colistin, and all six Acinetobacter spp. were sensitive to minocycline, colistin and tigecycline. Of those patients harboring carbapenemase-producing Gram-negative bacilli, 12 (54.5%) were seriously ill at the time of admission, with longer hospital stays and three deaths (13.6% mortality rate).
CONCLUSIONS: Urinary tract infection-causing carbapenem-resistant Gram-negative bacilli are widely disseminated in Indonesia. The NDM-1 phenotype seems to be dominant, and it can be treated with colistin and tigecycline in most cases. Most patients harboring carbapenemase-producing Gram-negative bacilli are seriously ill, have a bad prognosis, with a longer hospital stay and a significant mortality rate.
© 2018 The Japanese Urological Association.

Entities:  

Keywords:  zzm321990Enterobacteriaceaezzm321990; zzm321990Pseudomonaszzm321990; carbapenem resistance; multidrug resistance; urinary tract infection

Mesh:

Substances:

Year:  2018        PMID: 30253445     DOI: 10.1111/iju.13787

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  4 in total

1.  Effect of Ciprofloxacin, Levofloxacin, and Ofloxacin on Pseudomonas aeruginosa: A case control study with time kill curve analysis.

Authors:  Tiar Sondang Uli Sihotang; Agung Dwi Wahyu Widodo; Pepy Dwi Endraswari
Journal:  Ann Med Surg (Lond)       Date:  2022-09-16

2.  The Economic Impact of Carbapenem Resistant-Non Lactose Fermenter and Enterobacteriaceae Infections on Hospital Costs in Dr. Soetomo General Academic Hospital Surabaya, Indonesia.

Authors:  Yasmeen Lashari; Maftuchah Rochmanti; Abdul Khairul Rizki Purba; Hari Basuki Notobroto; Rosantia Sarassari; Kuntaman Kuntaman
Journal:  Antibiotics (Basel)       Date:  2022-05-20

3.  Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia.

Authors:  Ryan K Shields; Yun Zhou; Hemanth Kanakamedala; Bin Cai
Journal:  BMC Infect Dis       Date:  2021-06-14       Impact factor: 3.090

4.  Clinical impact of endemic NDM-producing Klebsiella pneumoniae in intensive care units of the national referral hospital in Jakarta, Indonesia.

Authors:  Yulia Rosa Saharman; Anis Karuniawati; Rudyanto Sedono; Dita Aditianingsih; Wil H F Goessens; Corné H W Klaassen; Henri A Verbrugh; Juliëtte A Severin
Journal:  Antimicrob Resist Infect Control       Date:  2020-05-11       Impact factor: 4.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.